Results 91 to 100 of about 115,914 (189)

Increased Lymphocyte Proportions as a Candidate Biomarker for Immune‐Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors and Chemotherapy

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Combination therapy comprising immune checkpoint inhibitors (ICIs) and chemotherapy is standard treatment for many cancer types. However, the management of adverse events (AEs) induced by combination therapy is more complicated than that of AEs induced by ICI monotherapy.
Nanami Ito, Yoshihiko Tasaki, Yosuke Sugiyama, Takehiro Uemura, Keisuke Yokota, Ryo Ogawa, Takaya Shimura, Daisuke Kawakita, Yumi Wanifuchi‐Endo, Yoshihisa Mimura, Moeko Iida, Kunihiro Odagiri, Yuka Kimura, Misato Tomita, Yuji Hotta, Tatsuya Toyama, Shinichi Iwasaki, Hiromi Kataoka, Shuji Takiguchi, Katsuhiro Okuda, Akio Niimi, Yoko Furukawa‐Hibi   +21 more
wiley   +1 more source

Mycophenolate-induced eosinophilic colitis: A case report

, 2023
RESUMEN: El micofenolato de mofetil es un medicamento usado para la prevención del rechazo de aloinjertos en pacientes con trasplante de órganos. La colitis eosinofílica por micofenolato es una condición reconocida en pacientes con antecedente de ...
Arteta Cueto, Ariel Antonio, Caviedes Cleves, Mario Alberto   +1 more
core   +1 more source

Eosinophilic Digestive Disease (EDD) and Allergic Bronchial Asthma; Two Diseases or Expression of One Disease in Two Systems?

Italian Journal of Pediatrics, 2011
Eosinophilic digestive disease (EDD) includes a broad spectrum of clinical presentations due to eosinophilic inflammation involving anywhere from the esophagus to the rectum.
Yakoot Mostafa
doaj   +1 more source

Mucosal‐Associated Invariant T Cells in Health and Disease

MedComm, Volume 7, Issue 10, October 2026.
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao, Feng‐Mi Ou, Dan Liang, Yang Gao, Qing‐Qing Li, Yi‐Qun Kuang   +5 more
wiley   +1 more source

Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment

MedComm, Volume 7, Issue 10, October 2026.
The liver is not merely a passive recipient of disseminated tumor cells, but a unique metastatic organ shaped by anatomical, metabolic, and immunological characteristics that support tumor colonization. Increasing evidence indicates that colorectal cancer liver metastasis development is driven by dynamic interactions between tumor intrinsic programs ...
Jialiang Fan, Huiru Zhang, Deyang Kong, Yu Sun, Shuaibing Lu, Wenjing Yang, Renshen Xiang, Qi Zhang, Wei Pei, Haizeng Zhang, Lin Feng   +10 more
wiley   +1 more source

Carbon Quantum Dots: From Mechanisms to Biomedical Applications

MedComm, Volume 7, Issue 10, October 2026.
Carbon quantum dots (CQDs) are promising carbon‐based nanomaterials with broad biomedical applications, including bioimaging, drug delivery, biosensing, and tissue regeneration. This Review summarizes the biological mechanisms of CQDs in tissue regeneration, focusing on their regulation of cellular functions, immune responses, and redox balance.
Bingxin Fan, Nianqiang Jin, Nuo Jin, Jiayu Shen, Xinliang Duan, Sichen Han, Yao Yuan, Zilin Wang   +7 more
wiley   +1 more source

Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape

Aging Cell, Volume 25, Issue 10, October 2026.
Elderly human donor microbiota disrupts intestinal barrier integrity and reshapes host metabolic and mucosal transcriptional profiles in human microbiota‐associated pigs. Integrated multi‐omics analyses identify coordinated microbial, metabolic, and host alterations associated with age‐related intestinal decline.
Jiaxin Wang, Lingyu Li, Lihua Mei, Zhining Tang, Baorui Liao, Qianye Zhao, Yuzeng Wang, Qingyao Fu, Liu Ren, Zhian Zhai, Yifei Xu, Aoyu Yang, Shuai Duan, Zhengyuan Zhai, Yanling Hao, Yalin Zhou, Yajun Xu, Ying Yang, Zhenlong Wu, Yun Ji   +19 more
wiley   +1 more source

Late‐Onset Mesalazine‐Induced Eosinophilic Pneumonitis Presenting as Non‐Resolving Pneumonia: A Diagnostic Pitfall in Ulcerative Colitis

Clinical Case Reports
Mesalazine is widely used in the management of ulcerative colitis and is generally well tolerated. Rarely, it can cause eosinophilic pneumonitis, a potentially serious form of drug‐induced lung injury that often mimics infection.
Siraj Nasim, Tamer Mohamed Zaalouk, Abu Bocus, Maged Kerols   +3 more
doaj   +1 more source

Gastrointestinal: Eosinophilic colitis [PDF]

Journal of Gastroenterology and Hepatology, 2008
L S E, Shim, G D, Eslick, J S, Kalantar
openaire   +2 more sources

A Hypereosinophilic Syndrome Presenting as Eosinophilic Colitis

Clinical Endoscopy, 2012
HYPEREOSINOPHILIC SYNDROME (HES) HAS THREE DEFINING FEATURES: marked hypereosinophilia for at least 6 months, no confirmed etiology for the eosinophilia, and eosinophilia-related symptoms or organ dysfunction. However, a shorter period of hypereosinophilia with symptoms requiring eosinophil-lowering therapy is also acceptable.
Jeon, Young Woo, Hong, Su Jin, Kim, Hwa Jong, Han, Jae Pil, Kim, Hee Kyung, Ko, Bong Min, Park, Sung Kyu, Lee, Moon Sung   +7 more
openaire   +2 more sources